Limited Liability Partnership registration number OC439575 (England and Wales)
BIOPHARMA RESEARCH EXPERTS LLP
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2024
PAGES FOR FILING WITH REGISTRAR
BIOPHARMA RESEARCH EXPERTS LLP
CONTENTS
Page
Balance sheet and notes to the financial statements
1 - 2
BIOPHARMA RESEARCH EXPERTS LLP
BALANCE SHEET
AS AT 31 OCTOBER 2024
31 October 2024
- 1 -
2024
2023
£
£
£
£
Current assets
1,771
4,561
Creditors: amounts falling due within one year
(31,026)
(31,937)
Net current liabilities
(29,255)
(27,376)
Net liabilities attributable to members
(29,255)
(27,376)
Represented by:
Loans and other debts due to members
-
-
Members' other interests
(29,255)
(27,376)
(29,255)
(27,376)
Notes to the financial statements
1
Employees
The average number of persons, excluding members, employed by the partnership during the year was as follows:
2024
2023
Number
Number
Employees
2
2
2
Going concern
The LLP ceased trading on 31 October 2024 and it is the intention of the members to dissolve the LLP after the year end.
The members of thetrue LLP have elected not to include a copy of the profit and loss account within the financial statements.
BioPharma Research Experts LLP is a Limited Liability Partnership incorporated in England and Wales. The registered office is 29-31 Castle Street, High Wycombe, Buckinghamshire, United Kingdom, HP13 6RU.
For the financial year ended 31 October 2024 the Limited Liability Partnership was entitled to exemption from audit under section 477 of the Companies Act 2006 (as applied by the Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008) relating to small limited liability partnerships.
The members acknowledge their responsibilities for complying with the requirements of the Act (as applied to limited liability partnerships) with respect to accounting records and the preparation of accounts.
These financial statements have been prepared in accordance with the micro-entity provisions and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime' and delivered in accordance with the provisions applicable to LLPs subject to the small LLPs regime.
BIOPHARMA RESEARCH EXPERTS LLP
BALANCE SHEET (CONTINUED)
AS AT 31 OCTOBER 2024
31 October 2024
- 2 -
The financial statements were approved by the members and authorised for issue on 21 January 2025 and are signed on its behalf by:
BioPharma Consulting Limited
Designated member
Limited Liability Partnership registration number OC439575 (England and Wales)